Should cT2N0M0 be managed as a localized or locally advanced esophageal carcinoma?

Nicola Fazio¹, Emilio Bertani², Chiara Alessandra Cella^{1

3}

Affiliations

¹ Unit of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy.
² Division of Hepatobiliary Surgery, European Institute of Oncology, Milan, Italy.
³ Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Editorial

Nicola Fazio et al. J Thorac Dis. 2017 Sep.

. 2017 Sep;9(9):2829-2834.

doi: 10.21037/jtd.2017.08.82.

Nicola Fazio¹, Emilio Bertani², Chiara Alessandra Cella^{1

3}

¹ Unit of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy.
² Division of Hepatobiliary Surgery, European Institute of Oncology, Milan, Italy.
³ Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.
Markar SR, Gronnier C, Pasquer A, Duhamel A, Beal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Meunier B, Collet D, Mariette C; FREGAT working group – FRENCH – AFC. Markar SR, et al. Eur J Cancer. 2016 Mar;56:59-68. doi: 10.1016/j.ejca.2015.11.024. Epub 2016 Jan 23. Eur J Cancer. 2016. PMID: 26808298

1. Castro C, Bosetti C, Malvezzi M, et al. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015. Ann Oncol 2014;25:283-90. 10.1093/annonc/mdt486 - DOI - PubMed
1. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7. 10.1001/jama.281.17.1623 - DOI - PubMed
1. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74. 10.1200/JCO.2002.20.5.1167 - DOI - PubMed
1. Bedenne L, Michel P, Bouché O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007;25:1160-8. 10.1200/JCO.2005.04.7118 - DOI - PubMed
1. van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074-84. 10.1056/NEJMoa1112088 - DOI - PubMed